Operating
Net Income
Moderna Net Income decreased by 62.6% to -$1.34B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 38.3%, from -$971M to -$1.34B. Over 4 years (FY 2021 to FY 2025), Net Income shows a downward trend with a -30.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryProfitability
SignalHigher is better
VolatilityVolatile
First reportedQ1 2016
Last reportedQ1 2026May 1, 2026
How to read this metric
An increase indicates growing profitability, while a decrease suggests declining margins or rising costs.
Detailed definition
Net income represents the total profit or loss of a company after all operating expenses, taxes, and interest have been...
Peer comparison
Standard across all public companies; essential for calculating earnings per share and return on equity.
Metric ID:
net_income_cfHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.78B | $3.33B | $4.87B | $3.66B | $2.2B | $1.04B | $1.47B | $79M | -$1.38B | -$3.63B | $0 | -$1.18B | -$1.28B | $13M | -$1.12B | -$971M | -$825M | -$200M | -$826M | -$1.34B |
| QoQ Change | — | +19.9% | +46.1% | -24.9% | -39.9% | -52.5% | +40.5% | -94.6% | <-999% | -163.0% | +100.0% | — | -8.9% | +101.0% | <-999% | +13.3% | +15.0% | +75.8% | -313.0% | -62.6% |
| YoY Change | — | — | — | — | -21.0% | -68.7% | -69.9% | -97.8% | -162.8% | -448.0% | -100.0% | <-999% | +7.3% | +100.4% | — | +17.4% | +35.5% | <-999% | +26.3% | -38.3% |
Range-$3.63B – $4.87B
CAGR-14.2%
Avg YoY Growth-269.7%
Median YoY Growth-68.7%
Current Streak2 quarters decline
Net Income at Other Companies
Frequently Asked Questions
- What is Moderna's net income?
- Moderna (MRNA) reported net income of -$1.34B in Q1 2026.
- How has Moderna's net income changed year-over-year?
- Moderna's net income decreased by 38.3% year-over-year, from -$971M to -$1.34B.
- What is the long-term trend for Moderna's net income?
- Over 4 years (2021 to 2025), Moderna's net income has grown at a -30.7% compound annual growth rate (CAGR), from $12.2B to -$2.82B.
- What does net income mean?
- The total profit or loss a company earned during a specific period.